Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 16495056)

1.

Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.

Lafite P, Dijols S, Buisson D, Macherey AC, Zeldin DC, Dansette PM, Mansuy D.

Bioorg Med Chem Lett. 2006 May 15;16(10):2777-80. Epub 2006 Feb 21.

2.

Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.

Xu M, Ju W, Hao H, Wang G, Li P.

Drug Metab Rev. 2013 Aug;45(3):311-52. doi: 10.3109/03602532.2013.806537. Review.

PMID:
23865864
3.

Magnetic resonance study of the structure and functions of cytochrome P450.

Weiner LM.

CRC Crit Rev Biochem. 1986;20(2):139-200. Review.

PMID:
3011356
4.

Structural basis of selective cytochrome P450 inhibition.

Halpert JR.

Annu Rev Pharmacol Toxicol. 1995;35:29-53. Review.

PMID:
7598496
6.

Inhibition and induction of human cytochrome P450 (CYP) enzymes.

Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H.

Xenobiotica. 1998 Dec;28(12):1203-53. Review. No abstract available.

PMID:
9890159
7.
8.

In vitro assessment of human cytochrome P450.

Clarke SE.

Xenobiotica. 1998 Dec;28(12):1167-202. Review. No abstract available.

PMID:
9890158
9.

Cytochrome P450 metabolism and inhibition: analysis for drug discovery.

Jones BC, Middleton DS, Youdim K.

Prog Med Chem. 2009;47:239-63. doi: 10.1016/S0079-6468(08)00206-3. Review. No abstract available.

PMID:
19328293
10.

Molecular basis of P450 inhibition and activation: implications for drug development and drug therapy.

Szklarz GD, Halpert JR.

Drug Metab Dispos. 1998 Dec;26(12):1179-84. Review.

11.

Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.

Spiecker M, Liao J.

Trends Cardiovasc Med. 2006 Aug;16(6):204-8. Review.

PMID:
16839864
12.

Pesticide-metabolizing enzymes.

Hodgson E, Rose RL, Ryu DY, Falls G, Blake BL, Levi PE.

Toxicol Lett. 1995 Dec;82-83:73-81. Review.

PMID:
8597134
13.
14.

Luminogenic cytochrome P450 assays.

Cali JJ, Ma D, Sobol M, Simpson DJ, Frackman S, Good TD, Daily WJ, Liu D.

Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):629-45. Review.

PMID:
16859410
15.

Inhibition of cytochromes p450: existing and new promising therapeutic targets.

Schuster I, Bernhardt R.

Drug Metab Rev. 2007;39(2-3):481-99. Review.

PMID:
17786634
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk